Evidence mapPaperPMID 38638701Full record

ArticleRegenerative biomaterials2024

Adaptation process of decellularized vascular grafts as hemodialysis access

Tun Wang, Peng Lu, Zicheng Wan, Zhenyu He, Siyuan Cheng, Yang Zhou, Sheng Liao, Mo Wang, Tianjian Wang, Chang Shu

Open access · goldAbstract read
In one paragraph

Article in Regenerative biomaterials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Tun WangDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Peng LuDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zicheng WanDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zhenyu HeDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Siyuan ChengDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Yang ZhouDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Sheng LiaoDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Mo WangDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Tianjian WangDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Chang ShuDepartment of Vascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.ORCID https://orcid.org/0000-0002-5096-4655
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Arteriovenous grafts (AVGs) have emerged as the preferred option for constructing hemodialysis access in numerous patients. Clinical trials have demonstrated that decellularized vascular graft exhibits superior patency and excellent biocompatibility compared to polymer materials; however, it still faces challenges such as intimal hyperplasia and luminal dilation. The absence of suitable animal models hinders our ability to describe and explain the pathological phenomena above and

Indexed as

animal modelarteriovenous graftdecellularized vascular graftsimmune cell infiltrationin vivo revascularization

Identifiers

PMID38638701
PMCPMC11026144
OpenAlexW4394962207

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.